prof. Veerle Surmont
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - VEERLE.SURMONT@UGent.be
Show
Sort by
-
- Journal Article
- A1
- open access
Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome
-
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials
-
- Journal Article
- A1
- open access
Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients : the PRO-long study
-
Coping strategy influences quality of life in patients with advanced lung cancer by mediating mood
-
- Miscellaneous
- open access
Lung Cancer in Belgium
-
Immuno-radiotherapy in solid tumors: preliminary results of the randomized phase 2 CHEERS trial.
-
- Journal Article
- A1
- open access
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial
-
- Journal Article
- A2
- open access
Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation : a case report
-
Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer : results from the Belgian compassionate use program
-
A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)